These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 2418645)
1. Treatment of posthypoxic action myoclonus: implications for the pathophysiology of the disorder. Chadwick D; Hallett M; Jenner P; Marsden CD Adv Neurol; 1986; 43():183-90. PubMed ID: 2418645 [No Abstract] [Full Text] [Related]
2. Biochemistry and therapeutics of posthypoxic myoclonus. Van Woert MH; Rosenbaum D; Chung EY Adv Neurol; 1986; 43():171-81. PubMed ID: 2418644 [No Abstract] [Full Text] [Related]
4. Beneficial effects of serotonin precursors in postanoxic action myoclonus. De Léan J; Richardson JC; Hornykiewicz O Neurology; 1976 Sep; 26(9):863-8. PubMed ID: 1084968 [TBL] [Abstract][Full Text] [Related]
5. Clinical, biochemical, and physiological features distinguishing myoclonus responsive to 5-hydroxytryptophan, tryptophan with a monoamine oxidase inhibitor, and clonazepam. Chadwick D; Hallett M; Harris R; Jenner P; Reynolds EH; Marsden CD Brain; 1977 Sep; 100(3):455-87. PubMed ID: 412560 [TBL] [Abstract][Full Text] [Related]
6. Pathological findings in a case of hypoxic myoclonus treated with 5-hydroxytryptophan and a decarboxylase inhibitor. De Léan J; Richardson JC; Rewcastle NB Adv Neurol; 1986; 43():215-23. PubMed ID: 2418647 [TBL] [Abstract][Full Text] [Related]
7. Clinical, biochemical, and pharmacological observation in a patient with postasphyxic myoclonus: association to serotonin hyperactivity. Giménez-Roldán S; Mateo D; Muradas V; De Yebenes JG Clin Neuropharmacol; 1988 Apr; 11(2):151-60. PubMed ID: 2454156 [TBL] [Abstract][Full Text] [Related]
8. Therapy of intention myoclonus with L-5-hydroxytryptophan and a peripheral decarboxylase inhibitor, MK 486. Van Woert MH; Sethy VH Neurology; 1975 Feb; 25(2):135-40. PubMed ID: 1078720 [TBL] [Abstract][Full Text] [Related]
9. Newer drugs for posthypoxic action myoclonus: observations from a well-studied case. Fahn S Adv Neurol; 1986; 43():197-9. PubMed ID: 2418646 [No Abstract] [Full Text] [Related]
10. Mechanism of action of clonazepam in myoclonus in relation to effects on GABA and 5-HT. Jenner P; Pratt JA; Marsden CD Adv Neurol; 1986; 43():629-43. PubMed ID: 2418652 [TBL] [Abstract][Full Text] [Related]
12. Reticular reflex myoclonus: a physiological type of human post-hypoxic myoclonus. Hallett M; Chadwick D; Adam J; Marsden CD J Neurol Neurosurg Psychiatry; 1977 Mar; 40(3):253-64. PubMed ID: 301926 [TBL] [Abstract][Full Text] [Related]
13. Postanoxic myoclonus. Treatment of a case with 5-hydroxytryptophane and a decarboxylase inhibitor. Beretta E; Regli F; de Crousaz G; Steck AJ J Neurol; 1981; 225(1):57-62. PubMed ID: 6164757 [TBL] [Abstract][Full Text] [Related]
14. [Utilization of levo-5-hydroxytryptophan in post-anoxic myoclonus]. Rascol A; Guiraud-Chaumeil B; Laboucarie J; Montastruc JL; El-Hage W Therapie; 1978; 33(5):623-8. PubMed ID: 311085 [No Abstract] [Full Text] [Related]
15. Functional independence in post-anoxic myoclonus: contribution of L-5-HTP sodium valproate and clonazepam. Carroll WM; Walsh PJ Br Med J; 1978 Dec; 2(6152):1612. PubMed ID: 365292 [No Abstract] [Full Text] [Related]